Ox­ford gets £100M to seize a 'break­through mo­men­t' in fight­ing su­per­bugs

Close to 70 years af­ter Ox­ford sci­en­tists pu­ri­fied peni­cillin and con­firmed its ef­fect as an an­tibac­te­r­i­al drug, the uni­ver­si­ty is es­tab­lish­ing a new re­search in­sti­tute at the fore­front of com­bat­ing an­timi­cro­bial re­sis­tance.

The In­eos Ox­ford In­sti­tute for AMR Re­search will ini­tial­ly be pow­ered by a $136 mil­lion (£100 mil­lion) do­na­tion from In­eos, the UK-based chem­i­cals gi­ant found­ed by bil­lion­aire Jim Rat­cliffe, that al­so plays a hand in man­u­fac­tur­ing med­ical and phar­ma prod­ucts.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.